Ribomic Income Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	3	2	-	65	80
Revenue Growth (YoY)	50.00%	-	-	-18.75%	-12.09%
Gross Profit	3	2	-	65	80
Selling, General & Admin	407	385	352	361	313
Research & Development	803	667	764	1,491	1,482
Other Operating Expenses	-	-	-	-	34
Operating Expenses	1,210	1,052	1,116	1,852	1,829
Operating Income	-1,207	-1,050	-1,116	-1,787	-1,749
Interest & Investment Income	12	4	1	2	-
Currency Exchange Gain (Loss)	-	-	10	20	11
Other Non Operating Income (Expenses)	56	31	122	116	103
EBT Excluding Unusual Items	-1,139	-1,015	-983	-1,649	-1,635
Asset Writedown	-5	-2	-40	-3	-48
Pretax Income	-1,144	-1,017	-1,023	-1,652	-1,683
Income Tax Expense	1	1	1	1	1
Net Income	-1,145	-1,018	-1,024	-1,653	-1,684
Net Income to Common	-1,145	-1,018	-1,024	-1,653	-1,684
Shares Outstanding (Basic)	50	40	36	31	28
Shares Outstanding (Diluted)	50	40	36	31	28
Shares Change (YoY)	22.82%	13.25%	14.73%	10.70%	9.29%
EPS (Basic)	-23.06	-25.19	-28.69	-53.14	-59.92
EPS (Diluted)	-23.06	-25.19	-28.69	-53.14	-59.92
Free Cash Flow	-1,120	-1,028	-954	-1,731	-1,509
Free Cash Flow Per Share	-22.56	-25.43	-26.73	-55.64	-53.70
Gross Margin	100.00%	100.00%	-	100.00%	100.00%
Operating Margin	-40233.33%	-52500.00%	-	-2749.23%	-2186.25%
Profit Margin	-38166.67%	-50900.00%	-	-2543.08%	-2105.00%
Free Cash Flow Margin	-37333.33%	-51400.00%	-	-2663.08%	-1886.25%
EBITDA	-1,204	-1,049	-1,106	-1,787	-1,734
D&A For EBITDA	3	0.92	10	0.48	15
EBIT	-1,207	-1,050	-1,116	-1,787	-1,749